Patients with NASH were shown to have increased numbers of circulating microparticles from invariant natural killer T cells and macrophages/monocytes (CD14+), dominant cell types in mediating the pathogenesis of NASH [36]. Here, CD14 is linked to metabolic dysfunction-associated steatohepatitis.